Katarzyna Karwacz

Katarzyna Karwacz is an accomplished Immunologist specializing in T cell biology, immuno-oncology, inflammation, and autoimmune diseases.

With expertise in bispecific antibodies, antibody-mediated modulation of immune responses, and novel target discovery, she has a strong drug discovery background.

Her experience includes developing immunoassays, utilizing in vivo models, and testing immuno-modulatory antibodies and novel immunotherapeutic targets.

Katarzyna has a proven track record of coordinating academic and industry collaborations, as well as managing cross-functional teams.

She boasts an outstanding publication record in top-tier journals with over 1200 citations, including notable publications in Nature Immunology and EMBO Molecular Medicine.

Her research has been supported by 8 grants and research awards exceeding $600,000.

Education-wise, Katarzyna holds a Doctor of Philosophy (PhD) in Immunology, gene therapy, and immuno-oncology from UCL, and a Bachelor's Degree in Biochemistry and Cell Biology from Jacobs University Bremen.

With a history of working in esteemed organizations like Regeneron Pharmaceuticals, Inc. and Pfizer, she has held positions such as Staff Scientist and Senior Scientist in the field of Targeted Immunotherapeutics.

Her professional journey includes roles as a Postdoctoral Research Fellow at Harvard Medical School and Teaching Assistant positions at UCL and Jacobs University Bremen.

Katarzyna has also contributed as a Visiting Researcher at prestigious institutions like the California Institute of Technology and the University of California San Diego.